Gang Liu

US Patent:

7948042, May 24, 2011

Filed:

Mar 3, 2009

Appl. No.:

12/397183

Inventors:

Chun Ning Lau - Diamond Bar CA, US
Gang Liu - Riverside CA, US
Jairo Velasco, Jr. - Riverside CA, US

Assignee:

The Regents of the University of California - Oakland CA

International Classification:

H01L 29/84

US Classification:

257415, 257417, 257419, 257E43002, 257E43003, 257E43007, 257E27005, 257E27046, 257E27064

Abstract:

A multi-level lithography processes for the fabrication of suspended structures are presented. The process is based on the differential exposure and developing conditions of several a plurality of resist layers, without harsher processes, such as etching of sacrificial layers or the use of hardmasks. These manufacturing processes are readily suited for use with systems that are chemically and/or mechanically sensitive, such as graphene. Graphene p-n-p junctions with suspended top gates formed through these processes exhibit high mobility and control of local doping density and type. This fabrication technique may be further extended to fabricate other types of suspended structures, such as local current carrying wires for inducing local magnetic fields, a point contact for local injection of current, and moving parts in microelectromechanical devices.

US Patent:

8076344, Dec 13, 2011

Filed:

Apr 30, 2008

Appl. No.:

12/112643

Inventors:

Gang Liu - San Diego CA, US
Zhili Xin - Lake Bluff IL, US
Philip R. Kym - Libertyville IL, US
Andrew J. Souers - Evanston IL, US

Assignee:

Abbott Laboratories - Abbott Park IL

International Classification:

A01N 43/90
A61K 31/519
C07D 487/00

US Classification:

51425931, 544263

Abstract:

The present invention relates to compounds of formula (I):.

US Patent:

8349851, Jan 8, 2013

Filed:

Feb 26, 2010

Appl. No.:

12/714323

Inventors:

Sunny Abraham - San Diego CA, US
Qi Chao - San Diego CA, US
Michael J. Hadd - San Diego CA, US
Mark W. Holladay - San Diego CA, US
Gang Liu - San Diego CA, US
Eduardo Setti - San Mateo CA, US

Assignee:

Ambit Biosciences Corp. - San Diego CA

International Classification:

A61K 31/517

US Classification:

51426623, 544284

Abstract:

Provided herein are quinazoline compounds of formula (I):.

US Patent:

8557828, Oct 15, 2013

Filed:

Oct 20, 2011

Appl. No.:

13/277909

Inventors:

Gang Liu - San Diego CA, US
Zhili Xin - Lake Bluff IL, US
Philip R. Kym - Libertyville IL, US
Andrew J. Souers - Evanston IL, US

Assignee:

AbbVie Inc. - North Chicago IL

International Classification:

A01N 43/90
A61K 31/519

US Classification:

51425931

Abstract:

The present invention relates to compounds of formula (I):.

US Patent:

20110269740, Nov 3, 2011

Filed:

Jul 2, 2009

Appl. No.:

13/000606

Inventors:

Sunny Abraham - San Diego CA, US
Qi Chao - San Diego CA, US
Michael Hadd - San Diego CA, US
Mark Holladay - San Diego CA, US
Gang Liu - San Diego CA, US
Mitchell Nambu - San Diego CA, US
Eduardo Setti - San Mateo CA, US

International Classification:

A61K 31/53
A61K 31/5377
A61P 35/00
A61P 19/02
A61P 37/06
A61P 17/02
A61P 3/10
C07D 487/04
A61P 29/00

US Classification:

51421021, 544183, 514243, 544112, 5142332

Abstract:

Provided herein are pyrrolotriazine compounds for treatment of JAK kinase, including JAK2 kinase mediated diseases. Also provided are pharmaceutical compositions comprising the compounds and methods of using the compounds and compositions.

US Patent:

20130035326, Feb 7, 2013

Filed:

Aug 18, 2010

Appl. No.:

13/390911

Inventors:

Sunny Abraham - San Diego CA, US
Mark W. Holladay - San Diego CA, US
Gang Liu - San Diego CA, US
Shimin Xu - San Diego CA, US

Assignee:

AMBIT BIOSCIENCES CORPORATION - San Diego CA

International Classification:

C07D 413/12
C07D 498/04
A61K 31/5383
A61K 31/4375
C07D 471/04
C07D 413/14
A61K 31/444
A61K 31/553
A61K 31/4545
A61K 31/506
A61K 31/5377
A61K 31/505
C07D 401/12
A61K 31/497
A61K 31/437
A61K 31/5513
C07D 239/42
C07D 401/04
A61P 29/00
A61P 37/00
A61P 35/00
A61P 35/02
A61P 37/06
A61P 17/02
A61P 13/12
A61P 17/06
A61P 37/08
A61P 11/00
A61P 19/02
A61P 25/00
A61P 19/10
A61P 11/06
A61P 37/02
A61P 31/00
A61P 3/10
A61P 1/00
A61P 1/04
A61P 19/04
A61K 31/4439

US Classification:

5142111, 5462721, 514340, 544105, 5142305, 544131, 514300, 546122, 546256, 514333, 540552, 546194, 514318, 514343, 544331, 514272, 544122, 5142358, 5142368, 544123, 5462754, 514341, 544405, 51425505, 546116, 514302, 514303, 546118, 546119, 540502, 514221, 544332

Abstract:

Provided herein are compounds for treatment of KIT, CSF-1R and/or FLT3 kinase mediated diseases. Also provided are pharmaceutical compositions comprising the compounds and methods of using the compounds and compositions.

US Patent:

20130096113, Apr 18, 2013

Filed:

Oct 12, 2012

Appl. No.:

13/651312

Inventors:

Ambit Biosciences Corporation - San Diego CA, US
Michael D. Hocker - San Diego CA, US
Mark W. Holladay - San Diego CA, US
Gang Liu - San Diego CA, US
Martin W. Rowbottom - San Diego CA, US
Shimin Xu - San Diego CA, US

Assignee:

Ambit Biosciences Corporation - San Diego CA

International Classification:

A61K 31/428
C07D 471/04
A61K 31/437
C07D 417/14
A61K 31/5377
C07D 487/04
C07D 413/10
A61K 31/423
C07D 473/00
A61K 31/52
A61K 31/5025
A61P 29/00
A61P 37/06
A61P 35/00
A61P 35/02
A61P 9/10
A61P 9/08
A61P 11/08
A61P 3/04
A61P 3/14
A61P 5/50
A61P 13/12
A61P 37/04
A61P 17/02
A61P 25/00
A61P 5/14
A61P 3/10
A61P 17/00
A61P 17/06
A61P 37/08
A61P 1/00
A61P 1/04
A61P 19/04
A61P 19/02
A61P 19/08
A61P 19/10
A61P 15/00
A61P 11/00
A61P 25/28
C07D 417/10

US Classification:

5142332, 548159, 514367, 546118, 514303, 544135, 5142345, 544127, 5142342, 544117, 548222, 514375, 544264, 5142632, 544236, 514248

Abstract:

Provided herein are heterocyclic compounds for treatment of CSF1R, FLT3, KIT, and/or PDGFRβ kinase mediated diseases. Also provided are pharmaceutical compositions comprising the compounds and methods of using the compounds and compositions.

US Patent:

20130310357, Nov 21, 2013

Filed:

May 26, 2011

Appl. No.:

13/700121

Inventors:

Gang Liu - San Diego CA, US

Assignee:

AMBIT BIOSCIENCES CORPORATION - San Diego CA

International Classification:

C07D 401/14
C07D 413/12
C07D 455/02
C07D 453/02
A61K 31/4545
A61K 31/496
A61K 31/5377
A61K 31/4439
A61K 31/501
A61K 31/497
A61K 31/4375
A61K 31/439
C07D 451/02
A61K 45/06
C07D 413/14

US Classification:

5142102, 546194, 544364, 544131, 5462721, 544238, 544405, 546138, 546137, 514318, 5142531, 5142368, 514340, 51425203, 51425505, 514306, 514305

Abstract:

Provided herein are azolyl urea compounds for treatment of CSF-1R kinase mediated diseases. Also provided are pharmaceutical compositions comprising the compounds and methods of using the compounds and compositions.